Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,354 | 27,685 | 30,996 | 28,787 | 33,113 |
| TOTAL | $25,640 | $28,639 | $32,019 | $30,154 | $33,474 |
| Non-Current Assets | |||||
| PPE Net | 86 | 2 | 2 | 2 | 12 |
| Other Non-Current Assets | 40 | 40 | 0 | 0 | 136 |
| TOTAL | $127 | $42 | $2 | $2 | $148 |
| Total Assets | $25,766 | $28,681 | $32,020 | $30,156 | $33,622 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 863 | 1,131 | 826 | 843 | 1,136 |
| Accrued Expenses | 3,304 | 2,820 | 3,401 | 2,358 | 2,752 |
| TOTAL | $4,166 | $3,951 | $4,227 | $3,201 | $3,998 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,311 | 1,311 | 1,311 | 1,311 | 2,999 |
| TOTAL | $1,311 | $1,311 | $1,311 | $1,311 | $2,999 |
| Total Liabilities | $5,477 | $5,262 | $5,539 | $4,512 | $6,997 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,737 | 3,737 | 3,732 | 3,732 | 2,650 |
| Common Shares | 4 | 4 | 4 | 3 | 52 |
| Retained earnings | -304,640 | -301,435 | -298,176 | -293,796 | -291,354 |
| Other shareholders' equity | -10,636 | -10,635 | -10,561 | -10,623 | -10,241 |
| TOTAL | $20,289 | $23,419 | $26,482 | $25,644 | $26,625 |
| Total Liabilities And Equity | $25,766 | $28,681 | $32,021 | $30,156 | $33,622 |